NxStage Medical Inc.
NXTM
NXTM was delisted on the 21st of February, 2019.
140 hedge funds and large institutions have $1.3B invested in NxStage Medical Inc. in 2015 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 45 increasing their positions, 51 reducing their positions, and 13 closing their positions.
154% more call options, than puts
Call options by funds: $5.72M | Put options by funds: $2.25M
100% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 13
39% more capital invested
Capital invested by funds: $935M → $1.3B (+$361M)
10% more funds holding
Funds holding: 127 → 140 (+13)
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
12% less repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 51
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$40.4M |
| 2 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$15.4M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$13.2M |
| 4 |
CM
Castleark Management
Chicago,
Illinois
|
+$7.52M |
| 5 |
Millennium Management
New York
|
+$6.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$32.2M |
| 2 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
-$10.3M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$9.58M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$7.36M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$6.01M |
NXTM Hedge Fund Activity: Q4 2015 in Review
140 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in NxStage Medical Inc. (NXTM) for Q4 2015, worth a combined $1.3B — up 39% from $935M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new NXTM positions and 13 closed out — a net gain of 13 holders — while 45 added to existing stakes and 51 trimmed.
The largest buyer was Invesco, adding an estimated $40.4M. The largest seller was Deerfield Management, cutting an estimated $32.2M.
- 140 institutional investors held NxStage Medical Inc. (NXTM) as of Q4 2015, up from 127 in Q3 2015.
- Funds reported $1.3B of NxStage Medical Inc. stock for Q4 2015, up 39% quarter-over-quarter.
- 26 funds opened new NxStage Medical Inc. positions in Q4 2015 and 13 closed out, a net change of +13 holders.
- The largest NxStage Medical Inc. buyer in Q4 2015 was Invesco, an estimated $40.4M added.
- The largest NxStage Medical Inc. seller in Q4 2015 was Deerfield Management, an estimated $32.2M sold.
Based on aggregated 13F filings for Q4 2015.